Edward Morrow Atkinson III is VP at VERTEX PHARMACEUTICALS INC / MA (VRTX). They have made 3 open-market trades across 2 companies since 2023, most recently 2026-02-25.
CIK 0001914164
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VRTX | 19,100 | $9.5M |
| ETNB | 6,250 | $93K |
| Total | $9.6M |
Shares reported on the most recent Form 4, priced at the 2026-02-26 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VRTX | SELL · 10b5-1 | 2026-02-25 | 2026-02-26 | $486.35 | $325K | +3.9% | -7.7% | -9.0% |
| VRTX | SELL | 2026-02-17 | 2026-02-19 | $484.93 | $1.4M | +1.6% | -3.4% | -7.9% |
| VRTX | SELL · 10b5-1 | 2026-02-11 | 2026-02-12 | $460.43 | $806K | +2.4% | -1.2% | -3.9% |
| VRTX | SELL · 10b5-1 | 2025-11-17 | 2025-11-19 | $434.58 | $1.1M | +2.9% | +8.4% | +13.4% |
| VRTX | SELL · 10b5-1 | 2025-02-27 | 2025-02-28 | $475.34 | $1.3M | +3.7% | +1.5% | -6.4% |
| VRTX | SELL · 10b5-1 | 2025-02-25 | 2025-02-26 | $480.95 | $1.7M | +5.2% | +3.6% | -6.2% |
| VRTX | SELL · 10b5-1 | 2025-02-11 | 2025-02-12 | $459.83 | $1.6M | +5.7% | +11.1% | -4.9% |
| VRTX | SELL · 10b5-1 | 2024-06-12 | 2024-06-13 | $478.00 | $3.5M | -0.8% | +2.7% | -0.6% |
| VRTX | SELL · 10b5-1 | 2024-02-26 | 2024-02-27 | $425.70 | $752K | -3.7% | -2.7% | +4.0% |
| VRTX | SELL · 10b5-1 | 2024-02-21 | 2024-02-23 | $421.77 | $1.0M | -3.3% | -2.3% | +5.9% |
| VRTX | SELL · 10b5-1 | 2024-02-20 | 2024-02-21 | $420.79 | $674K | +1.0% | -1.0% | +5.3% |
| VRTX | SELL · 10b5-1 | 2024-02-12 | 2024-02-13 | $420.24 | $767K | +3.6% | -2.3% | +2.8% |
| ETNB | SELL | 2023-06-01 | 2023-06-05 | $17.91 | $224K | +3.6% | -4.4% | -12.5% |
| ETNB | SELL | 2023-03-01 | 2023-03-03 | $13.60 | $136K | -10.2% | +6.3% | +32.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.